Consult the medical resource doctors trust

UpToDate is one of the most respected evidence-based medical information resources in the world, used by over 400,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Clinical manifestations and diagnosis of Kawasaki disease

INTRODUCTION

Kawasaki disease (KD, also called mucocutaneous lymph node syndrome) is one of the most common vasculitides of childhood [1]. It is typically a self-limited condition, with fever and manifestations of acute inflammation lasting for an average of 12 days without therapy. However, complications such as coronary artery aneurysms, depressed myocardial contractility and heart failure, myocardial infarction, arrhythmias, and peripheral arterial occlusion may develop and lead to significant morbidity and mortality. (See "Cardiovascular sequelae of Kawasaki disease".)

The frequencies of aneurysm development and mortality have been dramatically decreased as a result of intravenous immune globulin (IVIG) therapy [2]. Expeditious diagnosis is critical to achieve the optimal treatment result.

The clinical manifestations and diagnosis of KD, including incomplete (atypical) KD will be discussed in this review. The epidemiology, etiology, treatment, and cardiac sequelae of Kawasaki disease are presented separately. (See "Epidemiology and etiology of Kawasaki disease" and "Initial treatment and prognosis of Kawasaki disease" and "Cardiovascular sequelae of Kawasaki disease".)

CLINICAL MANIFESTATIONS

KD is characterized by systemic inflammation manifested by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, rash, extremity changes and lymphadenopathy. These clinical signs are the basis for the diagnostic criteria for KD (table 1). These findings are often not present at the same time. As an example, the only clinical features some patients have developed by the time of admission are fever and cervical lymphadenopathy (KD with isolated cervical lymphadenopathy, KDiL) [3]. In one case series, these patients tended to be older and have a more severe course, with increased risk of coronary artery disease and lack of response to intravenous immune globulin. Thus, repeated histories and physical examinations are important in making a timely diagnosis of KD. (See 'Diagnosis' below.)

Fever — Fever is the most consistent manifestation of KD. It reflects elevated levels of proinflammatory cytokines such as tumor necrosis factor and interleukin-1, which are thought to mediate the underlying vascular inflammation [4]. Fever is minimally responsive to antipyretic agents, and remains above 38.5ºC during most of the illness. Patients are often described as irritable. The diagnosis of KD should be considered in all children with prolonged unexplained fever ≥5 days. (See 'Incomplete (atypical) KD' below.)

» To continue reading this article you need to login or subscribe.

Ready to join over 400,000 satisfied users? Subscribe to read this article and others like it.
Last literature review version 18.2: May 2010
This topic last updated: June 15, 2010
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References
Top
  1. Burns, JC, Glode, MP. Kawasaki syndrome. Lancet 2004; 364:533.
  2. Curtis, N, Levin, M. Kawasaki disease thirty years on. Curr Opin Pediatr 1998; 10:24.
  3. Nomura, Y, Arata, M, Koriyama, C, et al. A severe form of Kawasaki disease presenting with only fever and cervical lymphadenopathy at admission. J Pediatr 2010; 156:786.
  4. Leung, DY. The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease. Acta Paediatr Jpn 1991; 33:739.
  5. Germain, BF, Moroney, JD, Guggino, GS, et al. Anterior uveitis in Kawasaki disease. J Pediatr 1980; 97:780.
  6. Smith, LBH, Newburger, JW, Burns, JC. Kawasaki syndrome and the eye. Pediatr Infect Dis J 1989; 8:116.
  7. Eberhard, BA, Sundel, RP, Newburger, JW, et al. Psoriatic eruption in Kawasaki disease. J Pediatr 2000; 137:578.
  8. Wang, S, Best, BM, Burns, JC. Periungual desquamation in patients with Kawasaki disease. Pediatr Infect Dis J 2009; 28:538.
  9. Morens, DM, Anderson, LJ, Hurwitz, ES. National surveillance of Kawasaki disease. Pediatrics 1980; 65:21.
  10. Kawasaki, T, Kosaki, F, Okawa, S, et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54:271.
  11. Ichida, F, Fatica, NS, O'Loughlin, JE, et al. Epidemiologic aspects of Kawasaki disease in a Manhattan hospital. Pediatrics 1989; 84:235.
  12. Huang, GY, Ma, XJ, Huang, M, et al. Epidemiologic pictures of Kawasaki disease in Shanghai from 1998 through 2002. J Epidemiol 2006; 16:9.
  13. Gong, GW, McCrindle, BW, Ching, JC, Yeung, RS. Arthritis presenting during the acute phase of Kawasaki disease. J Pediatr 2006; 148:800.
  14. Melish, ME. Kawasaki syndrome: a 1986 perspective. Rheum Dis Clin North Am 1987; 13:7.
  15. Sung, RY, Ng, YM, Choi, KC, et al. Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease. Pediatr Infect Dis J 2006; 25:521.
  16. April, MM, Burns, JC, Newburger, JW, Healy, GB. Kawasaki disease and cervical adenopathy. Arch Otolaryngol Head Neck Surg 1989; 115:512.
  17. Baker, AL, Lu, M, Minich, LL, et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr 2009; 154:592.
  18. Shike, H, Kanegaye, JT, Best, BM, et al. Pyuria associated with acute Kawasaki disease and fever from other causes. Pediatr Infect Dis J 2009; 28:440.
  19. Watanabe, T, Abe, Y, Sato, S, et al. Sterile pyuria in patients with Kawasaki disease originates from both the urethra and the kidney. Pediatr Nephrol 2007; 22:987.
  20. Burns, JC, Mason, WH, Glode, MP, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. J Pediatr 1991; 118:680.
  21. Dengler, LD, Capparelli, EV, Bastian, JF, et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J 1998; 17:478.
  22. Korematsu, S, Uchiyama, S, Miyahara, H, et al. The characterization of cerebrospinal fluid and serum cytokines in patients with Kawasaki disease. Pediatr Infect Dis J 2007; 26:750.
  23. Hicks, RV, Melish, ME. Kawasaki syndrome. Pediatr Clin North Am 1986; 33:1151.
  24. Salo, E, Pesonen, I, Vilkari, J, et al. Serum cholesterol levels during and after Kawasaki disease. J Pediatr 1991; 119:557.
  25. Newburger, JW, Burns, JC, Beiser, AS, Loscalzo, J. Altered lipid profile after Kawasaki syndrome. Circulation 1991; 84:625.
  26. Cabana, VG, Gidding, SS, Getz, GS, et al. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res 1997; 42:651.
  27. Newburger, JW, Takahashi, M, Gerber, MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110:2747.
  28. Nakamura, Y, Yashiro, M, Uehara, R, et al. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 2004; 46:33.
  29. Kanegaye, JT, Wilder, MS, Molkara, D, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009; 123:e783.
  30. Son, MB, Gauvreau, K, Ma, L, et al. Treatment of Kawasaki disease: analysis of 27 US Pediatric Hospitals from 2001 to 2006. Pediatrics 2009; 124:1.
  31. Baer, AZ, Rubin, LG, Shapiro, CA, et al. Prevalence of coronary artery lesions on the initial echocardiogram in kawasaki syndrome. Arch Pediatr Adolesc Med 2006; 160:686.
  32. Yanagawa, H, Tuohong, Z, Oki, I, et al. Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease. Pediatr Cardiol 1999; 20:248.
  33. Burns, JC, Capparelli, EV, Brown, JA, et al. Intravenous gamma-globulin and retreatment in Kawasaki disease. Pediatr Infect Dis J 1998; 17:1144.
  34. McCrindle, BW, Li, JS, Minich, LL, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 2007; 116:174.
  35. Suzuki, A, Kamiya T, Kuwahara, N et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr cardiol 1986; 7:3.
  36. Koren, G, Lavi, S, Rose, V, Rowe, R. Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 1986; 108:388.
  37. Beiser, AS, Takahashi, M, Baker, AL, et al. A predictive instrument for coronary artery aneurysms in Kawasaki disease. Am J Cardiol 1998; 81:1116.
  38. Belay, ED, Maddox, RA, Holman, RC, et al. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J 2006; 25:245.
  39. Stockheim, JA, Innocentini, N, Shulman, ST. Kawasaki disease in older children and adolescents. J Pediatr 2000; 137:250.
  40. Momenah, T, Sanatani, S, Potts, J, et al. Kawasaki disease in the older child. Pediatrics 1998; 102:e7.
  41. Muta, H, Ishii, M, Sakaue, T, et al. Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease. Pediatrics 2004; 114:751.
  42. Uehara, R, Belay, ED, Maddox, RA, et al. Analysis of Potential Risk Factors Associated With Nonresponse to Initial Intravenous Immunoglobulin Treatment Among Kawasaki Disease Patients in Japan. Pediatr Infect Dis J 2008; 27:155.
  43. Manlhiot, C, Yeung, RS, Clarizia, NA, et al. Kawasaki disease at the extremes of the age spectrum. Pediatrics 2009; 124:e410.
  44. Song, D, Yeo, Y, Ha, K, et al. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr 2009; 168:1315.
  45. Yeo, Y, Kim, T, Ha, K, et al. Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr 2009; 168:157.
  46. Furusho, K, Kamiya, T, Nakano, H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984; 2:1055.
  47. Newburger, JW, Takahashi, M, Burns, JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315:341.
  48. Newburger, JW, Sanders, SP, Burns, JC, et al. Left ventricular contractility and function in Kawasaki syndrome. Circulation 1989; 79:1237.
  49. Yonesaka, S, Takahashi, T, Matubara, T, et al. Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle. Jpn Circ J 1992; 56:352.
  50. Tomita, S, Chung, K, Mas, M, et al. Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis 1992; 14:121.
  51. Tabarki, B, Mahdhaoui, A, Selmi, H, et al. Kawasaki disease with predominant central nervous system involvement. Pediatr Neurol 2001; 25:239.
  52. Suda, K, Matsumura, M, Ohta, S. Kawasaki disease complicated by cerebral infarction. Cardiol Young 2003; 13:103.
  53. Mele, T, Evans, M. Intestinal obstruction as a complication of Kawasaki disease. J Pediatr Surg 1996; 31:985.
  54. Akikusa, JD, Laxer, RM, Friedman, JN. Intestinal Pseudoobstruction in Kawasaki Disease. Pediatrics 2004; 113:E504.
  55. Zulian, F, Falcini, F, Zancan, L, et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr 2003; 142:731.
  56. Veiga, PA, Pieroni, D, Baier, W, Feld, LG. Association of Kawasaki disease and interstitial nephritis. Pediatr Nephrol 1992; 6:421.
  57. Ferriero, DM, Wolfsdorf, JI. Hemolytic uremic syndrome associated with Kawasaki disease. Pediatrics 1981; 68:405.
  58. Salcedo, JR, Greenberg, L, Kapur, S. Renal histology of mucocutaneous lymph node syndrome (Kawasaki disease). Clin Nephrol 1988; 29:47.
  59. Orbach, H, Tishler, M, Shoenfeld, Y. Intravenous immunoglobulin and the kidney--a two-edged sword. Semin Arthritis Rheum 2004; 34:593.
  60. Carlton-Conway, D, Ahluwalia, R, Henry, L, Michie, C. Behaviour sequelae following acute Kawasaki disease. BMC Pediatr 2005; 5:14.
  61. Baker, AL, Gauvreau, K, Newburger, JW, et al. Physical and psychosocial health in children who have had Kawasaki disease. Pediatrics 2003; 111:579.
  62. Muise, A, Tallett, SE, Silverman, ED. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome?. Pediatrics 2003; 112:e495.
  63. al-Eid, W, al-Jefri, A, Bahabri, S, al-Mayouf, S. Hemophagocytosis complicating Kawasaki disease. Pediatr Hematol Oncol 2000; 17:323.
  64. Palazzi, DL, McClain, KL, Kaplan, SL. Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J 2003; 22:663.
  65. Ohga, S, Ooshima, A, Fukushige, J, Ueda, K. Histiocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state. Eur J Pediatr 1995; 154:539.
  66. Latino, GA, Manlhiot, C, Yeung, RS, et al. Macrophage Activation Syndrome in the Acute Phase of Kawasaki Disease. J Pediatr Hematol Oncol 2010; :.
  67. Centers for Disease Control. Kawasaki disease — New York. MMWR Morb Mortal Wkly Rep 1980; 29:61.
  68. Ayusawa, M, Sonobe, T, Uemura, S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47:232.
  69. Uehara, R, Igarashi, H, Yashiro, M, et al. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guerin inoculation site. Pediatr Infect Dis J 2010; 29:430.
  70. Sundel, RP. Update on the treatment of kawasaki disease in childhood. Curr Rheumatol Rep 2002; 4:474.
  71. Minich, LL, Sleeper, LA, Atz, AM, et al. Delayed diagnosis of Kawasaki disease: what are the risk factors?. Pediatrics 2007; 120:e1434.
  72. Manlhiot, C, Yeung, RSM, Clarizia NA, et al. Kawasaki Disease at the Extremes of the Age Spectrum. Pediatrics 2009; 124:e410.
  73. Levy, M, Koren, G. Atypical Kawasaki disease: Analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J 1990; 9:122.
  74. Burns, JC, Wiggins, JW Jr, Toews, WH, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 1986; 109:759.
  75. Joffe, A, Kabani, A, Jadavji, T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med 1995; 162:322.
  76. Fukushige, J, Takahashi, HN, Ueda, Y, et al. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr 1994; 83:1057.
  77. Chang, FY, Hwang, B, Chen, SJ, et al. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J 2006; 25:241.
  78. Yanagihara, R, Todd, JK. Acute febrile mucocutaneous lymph node syndrome. Am J Dis Child 1980; 134:603.
  79. Barron, KS. Kawasaki disease in children. Curr Opin Rheumatol 1998; 10:29.
  80. Benseler, SM, McCrindle, BW, Silverman, ED, et al. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 2005; 116:e760.
Clinical manifestations and diagnosis of Kawasaki disease Initial treatment and prognosis of Kawasaki disease Epidemiology and etiology of Kawasaki disease Patient information: Permanent sterilization procedures for women Gastroesophageal reflux in premature infants